Carcinoma in situ of other parts of the cervix is a localized form of cervical cancer characterized by abnormal cell growth confined to the epithelial layer. It is primarily caused by persistent infection with high-risk human papillomavirus (HPV). Accurate coding with ICD-10 Code D06.7 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and follow-up.
ICD-10 Code D06.7 represents carcinoma in situ of other parts of the cervix, indicating the presence of abnormal cells that have not invaded surrounding tissues. This code is used in clinical documentation and billing when diagnosing patients with this specific condition, ensuring accurate representation of the patient's health status and facilitating appropriate treatment and follow-up.
Carcinoma in situ of other parts of the cervix is a precancerous condition that arises from the transformation of normal cervical epithelial cells due to factors such as HPV infection. If left untreated, it may progress to invasive cervical cancer, necessitating timely medical intervention.
ICD-10 Code D06.7 is utilized in SOAP notes to document the diagnosis of carcinoma in situ of other parts of the cervix. It plays a crucial role in capturing patient symptoms, assessment findings, and treatment plans, relevant in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D06.7 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ of other parts of the cervix. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
The management of carcinoma in situ of other parts of the cervix requires prompt intervention to prevent progression to invasive cancer. Treatment options may include surgical procedures and monitoring.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D06.7 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate reimbursement for services related to carcinoma in situ of the cervix.
| CPT Code | Description |
|---|---|
| 57500 | Colposcopy of the cervix, with biopsy. |
| 57522 | Loop electrosurgical excision procedure (LEEP). |
| 88141 | Cytopathology, cervical or vaginal, collected in preservative fluid. |
Common Questions About Using ICD-10 Code D06.7 for Carcinoma in situ of other parts of cervix
What are the risk factors for carcinoma in situ of the cervix?
Risk factors include persistent infection with high-risk HPV types, smoking, immunosuppression, and a history of cervical dysplasia. Regular screening can help identify precancerous changes early.
How is carcinoma in situ of the cervix treated?
Treatment options typically include surgical procedures such as LEEP or cone biopsy to remove abnormal cells. Follow-up care is essential to monitor for any recurrence or progression.
Is carcinoma in situ of the cervix contagious?
Carcinoma in situ itself is not contagious; however, the underlying cause, such as HPV, can be transmitted through sexual contact. Vaccination can help prevent HPV infection.
What is the prognosis for carcinoma in situ of the cervix?
The prognosis is generally favorable with appropriate treatment. Early detection and management significantly reduce the risk of progression to invasive cervical cancer.
Clinical Notes
SOAP notes
DAP notes
AI medical notes